COFFEE BREAK – What is a margin of error?

October 8, 2019
Our Coffee Break with Leger video clip series is designed to provide a brief overview of answers to key questions in the market research world. If you would like further information about the research services we provide, click the “Contact Us” button at the bottom of this page to get in touch with our team.

A margin of error is based on the laws of probability. It is the measure in percentage points of the known difference between the statistic (our sample result) and the parameter (meaning our entire population). It is thus the difference between what we have measured and the reality. The basic principle is rather simple: the greater the sample, the smaller the margin of error. However, there’s no use having disproportionately large samples. Most importantly, the sample must be representative.

For example, let’s say that our sample is the number of times we flip a coin to see if we get heads or tails. We know we have a 50-50 chance of flipping heads or tails. If you flip the coin 10 times, you may get 7 heads and 3 tails at random since your margin of error is large. If you flip the coin 100 times, your results will naturally get closer to 50-50, since the margin of error decreases as the sample becomes larger. But past 2000 flips, the decrease in the margin of error is so slight that there is no need to continue flipping.

In short, the margin of error is an indicator of the accuracy of our results. If, for example, there is a margin of error of 2% and a sample result of 30%, it means that the results might differ from the initial results by 2%, and the result may therefore fall between 28% and 32%.

Stephanie Lander is a Research Director at Leger. She joined the Healthcare Insights team after graduating from a Research Analyst post-graduate program in 2016. Stephanie manages both quantitative and qualitative projects for a variety of therapeutic areas and pharmaceutical/healthcare products. She regularly conducts research with healthcare professionals, patients, and consumers.

Related Posts

Cube AI Top 5 Ads of 2024: Ads That Made Us Smile

As 2024 comes to an end, our Cube AI experts are celebrating the ads that made us smile, laugh, and feel a little lighter. In a year full of twists, turns, and challenges, these campaigns reminded us of the power of emotion—taking us on journeys that were...

Self-Care and Bad Vibes: Generations Filled With Anxiety? 

Millennials and Gen Z continue to be at the forefront of the zeitgeist. While the repeated cultural debates of the appeal of skinny jeans and whether or not trad wives have it all are not without merit, brands and organisations need to go a bit deeper to better...

From Insight to Impact: How Market Research Fuels Pharma Creativity

The theme behind PharmaBrands Creativity Now! Conference highlighted a very important principle: in the highly regulated world of pharmaceutical marketing, creativity often thrives under constraints. While regulations can feel like obstacles, they also serve as a...

Get the latest in your inbox

Stay up to date on cutting-edge research, news and more.